annual total liabilities:
$4.02B-$515.74M(-11.37%)Summary
- As of today (May 29, 2025), CRL annual total liabilities is $4.02 billion, with the most recent change of -$515.74 million (-11.37%) on December 28, 2024.
- During the last 3 years, CRL annual total liabilities has fallen by -$412.03 million (-9.30%).
- CRL annual total liabilities is now -12.21% below its all-time high of $4.58 billion, reached on December 31, 2022.
Performance
CRL Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$4.34B+$320.32M(+7.97%)Summary
- As of today (May 29, 2025), CRL quarterly total liabilities is $4.34 billion, with the most recent change of +$320.32 million (+7.97%) on March 29, 2025.
- Over the past year, CRL quarterly total liabilities has dropped by -$108.27 million (-2.43%).
- CRL quarterly total liabilities is now -10.25% below its all-time high of $4.84 billion, reached on June 25, 2022.
Performance
CRL quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CRL Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.4% | -2.4% |
| 3 y3 years | -9.3% | -1.4% |
| 5 y5 years | +32.8% | +23.2% |
CRL Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.2% | at low | -10.3% | +8.0% |
| 5 y | 5-year | -12.2% | +32.8% | -10.3% | +32.0% |
| alltime | all time | -12.2% | +6020.1% | -10.3% | +1514.4% |
CRL Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $4.34B(+8.0%) |
| Dec 2024 | $4.02B(-11.4%) | $4.02B(-3.7%) |
| Sep 2024 | - | $4.18B(+0.0%) |
| Jun 2024 | - | $4.18B(-6.2%) |
| Mar 2024 | - | $4.45B(-1.9%) |
| Dec 2023 | $4.54B(-0.9%) | $4.54B(+6.6%) |
| Sep 2023 | - | $4.26B(-4.8%) |
| Jun 2023 | - | $4.47B(-1.5%) |
| Mar 2023 | - | $4.54B(-0.8%) |
| Dec 2022 | $4.58B(+3.3%) | $4.58B(-2.8%) |
| Sep 2022 | - | $4.71B(-2.6%) |
| Jun 2022 | - | $4.84B(+9.8%) |
| Mar 2022 | - | $4.40B(-0.6%) |
| Dec 2021 | $4.43B(+32.4%) | $4.43B(-3.5%) |
| Sep 2021 | - | $4.59B(+5.2%) |
| Jun 2021 | - | $4.37B(+21.5%) |
| Mar 2021 | - | $3.59B(+7.3%) |
| Dec 2020 | $3.35B(+10.6%) | $3.35B(+1.8%) |
| Sep 2020 | - | $3.29B(-5.0%) |
| Jun 2020 | - | $3.46B(-1.8%) |
| Mar 2020 | - | $3.52B(+16.4%) |
| Dec 2019 | $3.03B(+20.2%) | $3.03B(+0.3%) |
| Sep 2019 | - | $3.02B(-4.1%) |
| Jun 2019 | - | $3.15B(+25.6%) |
| Mar 2019 | - | $2.51B(-0.5%) |
| Dec 2018 | $2.52B(+34.9%) | $2.52B(-0.2%) |
| Sep 2018 | - | $2.52B(-5.3%) |
| Jun 2018 | - | $2.66B(+44.7%) |
| Mar 2018 | - | $1.84B(-1.3%) |
| Dec 2017 | $1.87B(+0.4%) | $1.87B(+2.2%) |
| Sep 2017 | - | $1.83B(+1.9%) |
| Jun 2017 | - | $1.79B(-0.6%) |
| Mar 2017 | - | $1.80B(-2.9%) |
| Dec 2016 | $1.86B(+42.6%) | $1.86B(+3.1%) |
| Sep 2016 | - | $1.80B(-5.2%) |
| Jun 2016 | - | $1.90B(+47.3%) |
| Mar 2016 | - | $1.29B(-1.0%) |
| Dec 2015 | $1.30B(+11.7%) | $1.30B(+0.5%) |
| Sep 2015 | - | $1.30B(+12.8%) |
| Jun 2015 | - | $1.15B(-0.0%) |
| Mar 2015 | - | $1.15B(-1.4%) |
| Dec 2014 | $1.17B(+20.5%) | $1.17B(+1.9%) |
| Sep 2014 | - | $1.14B(-1.8%) |
| Jun 2014 | - | $1.16B(+25.0%) |
| Mar 2014 | - | $931.50M(-3.8%) |
| Dec 2013 | $968.10M(-1.5%) | $968.10M(-0.2%) |
| Sep 2013 | - | $969.74M(+1.1%) |
| Jun 2013 | - | $959.21M(-0.5%) |
| Mar 2013 | - | $963.94M(-2.0%) |
| Dec 2012 | $983.14M | $983.14M(+1.6%) |
| Sep 2012 | - | $967.67M(-1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $981.22M(-2.0%) |
| Mar 2012 | - | $1.00B(-2.9%) |
| Dec 2011 | $1.03B(-1.3%) | $1.03B(-1.2%) |
| Sep 2011 | - | $1.04B(-6.4%) |
| Jun 2011 | - | $1.11B(-5.5%) |
| Mar 2011 | - | $1.18B(+13.0%) |
| Dec 2010 | $1.04B(+25.8%) | $1.04B(+0.2%) |
| Sep 2010 | - | $1.04B(+36.6%) |
| Jun 2010 | - | $762.62M(-5.1%) |
| Mar 2010 | - | $803.18M(-3.3%) |
| Dec 2009 | $830.27M(-13.6%) | $830.27M(-1.4%) |
| Sep 2009 | - | $842.36M(-3.3%) |
| Jun 2009 | - | $870.66M(+0.1%) |
| Mar 2009 | - | $869.55M(-9.5%) |
| Dec 2008 | $960.47M(+2.0%) | $960.47M(+1.2%) |
| Sep 2008 | - | $948.81M(+0.7%) |
| Jun 2008 | - | $942.01M(+1.2%) |
| Mar 2008 | - | $931.23M(-1.1%) |
| Dec 2007 | $941.57M(-1.2%) | $941.57M(+1.2%) |
| Sep 2007 | - | $930.21M(-0.1%) |
| Jun 2007 | - | $930.79M(+0.8%) |
| Mar 2007 | - | $923.76M(-3.1%) |
| Dec 2006 | $953.11M(+35.9%) | $953.11M(+1.3%) |
| Sep 2006 | - | $940.54M(-2.8%) |
| Jun 2006 | - | $967.29M(+45.4%) |
| Mar 2006 | - | $665.13M(-5.2%) |
| Dec 2005 | $701.48M(-38.7%) | $701.48M(-11.7%) |
| Sep 2005 | - | $794.11M(-1.6%) |
| Jun 2005 | - | $807.13M(-26.6%) |
| Mar 2005 | - | $1.10B(-3.9%) |
| Dec 2004 | $1.14B(+252.4%) | $1.14B(+230.0%) |
| Sep 2004 | - | $346.81M(+3.9%) |
| Jun 2004 | - | $333.84M(+3.5%) |
| Mar 2004 | - | $322.44M(-0.7%) |
| Dec 2003 | $324.75M(-0.2%) | $324.75M(+0.3%) |
| Sep 2003 | - | $323.67M(+2.3%) |
| Jun 2003 | - | $316.28M(-0.3%) |
| Mar 2003 | - | $317.10M(-2.6%) |
| Dec 2002 | $325.40M(+21.0%) | $325.40M(+6.2%) |
| Sep 2002 | - | $306.53M(-0.1%) |
| Jun 2002 | - | $306.96M(-15.6%) |
| Mar 2002 | - | $363.85M(+35.3%) |
| Dec 2001 | $268.86M(-4.1%) | $268.86M(-8.7%) |
| Sep 2001 | - | $294.41M(-0.6%) |
| Jun 2001 | - | $296.12M(-14.0%) |
| Mar 2001 | - | $344.28M(+22.8%) |
| Dec 2000 | $280.35M(-40.7%) | $280.35M(-0.7%) |
| Sep 2000 | - | $282.41M(-42.7%) |
| Jun 2000 | - | $493.09M(-1.1%) |
| Mar 2000 | - | $498.62M |
| Dec 1999 | $472.89M(+619.9%) | - |
| Dec 1998 | $65.69M | - |
FAQ
- What is Charles River Laboratories International annual total liabilities?
- What is the all time high annual total liabilities for Charles River Laboratories International?
- What is Charles River Laboratories International annual total liabilities year-on-year change?
- What is Charles River Laboratories International quarterly total liabilities?
- What is the all time high quarterly total liabilities for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly total liabilities year-on-year change?
What is Charles River Laboratories International annual total liabilities?
The current annual total liabilities of CRL is $4.02B
What is the all time high annual total liabilities for Charles River Laboratories International?
Charles River Laboratories International all-time high annual total liabilities is $4.58B
What is Charles River Laboratories International annual total liabilities year-on-year change?
Over the past year, CRL annual total liabilities has changed by -$515.74M (-11.37%)
What is Charles River Laboratories International quarterly total liabilities?
The current quarterly total liabilities of CRL is $4.34B
What is the all time high quarterly total liabilities for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly total liabilities is $4.84B
What is Charles River Laboratories International quarterly total liabilities year-on-year change?
Over the past year, CRL quarterly total liabilities has changed by -$108.27M (-2.43%)